|
|
| | N-(4-bromophenyl)-2-(6-ethylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetamide Basic information |
| | N-(4-bromophenyl)-2-(6-ethylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetamide Chemical Properties |
| Boiling point | 603.3±55.0 °C(Predicted) | | density | 1.59±0.1 g/cm3(Predicted) | | pka | 11.99±0.70(Predicted) |
| | N-(4-bromophenyl)-2-(6-ethylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetamide Usage And Synthesis |
| Uses | p38 MAPK-IN-6 (compound c47) is a p38 MAPK inhibitor. p38 MAPK-IN-6 shows 14% inhibition at 10 μM[1]. | | References | [1] Cheeseright TJ, et al.Novel lead structures for p38 MAP kinase via FieldScreen virtual screening. J Med Chem. 2009 Jul 23;52(14):4200-9. DOI:10.1021/jm801399r |
| | N-(4-bromophenyl)-2-(6-ethylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetamide Preparation Products And Raw materials |
|